Methods in Pharmacoepidemiology
Poster Session: Poster Session C
Vicki Osborne, PhD
– Jazz Pharmaceuticals, Cambridge, Cambridgeshire, United KingdomDeborah Layton, PhD, FISPE
– Principal, PEPI Consultancy Limited, Southampton, England, United KingdomAmie Goodin, PhD, MPP
– University of Florida, Gainesville, Florida, United StatesAlmut Winterstein, PhD, FISPE
– Distinguished Professor, University of Florida, Gainesville, Florida, United StatesAndrew Bate
– GSK, United KingdomCatherine Cohet, PhD
– Pharmacoepidemiology/RWE Senior Specialist, European Medicines Agency, Amsterdam, Noord-Holland, NetherlandsXavier Kurz, MD
– Head of Data Analytics, European Medicines Agency, Amsterdam, Noord-Holland, NetherlandsLisa Pont
– Professor, AustraliaDavid Moeny, MPH
– US Food and Drug Administration, Silver Spring, Maryland, United StatesOlaf H. Klungel, PharmD, PhD, FISPE
– Professor of pharmacoepidemiology, University of Utrecht, Utrecht, NetherlandsSimone P. Pinheiro, MSc, ScD
– Senior Director/Head, AbbVie, North Chicago, Illinois, United StatesJohn D. Seeger, PharmD, FISPE
– Optum Epidemiology, Boston, Massachusetts, United StatesK. Arnold Chan, MD, ScD, FISPE
– Professor, National Taiwan University, Taipei, Taipei, Taiwan (Republic of China)Joshua Brown, PharmD, PhD
– Assistant Professor, Center for Drug Evaluation and Safety, Department of Pharmaceutical Outcomes & Policy, University of Florida College of Pharmacy, Gainesville, FL USA, Gainesville, FL, United States